Cargando...

Bioavailability and toxicity after oral administration of m-iodobenzylguanidine (MIBG)

meta-iodobenzylguanidine (MIBG) radiolabelled with iodine-131 is used for diagnosis and treatment of neuroadrenergic neoplasms such as phaeochromocytoma and neuroblastoma. In addition, non-radiolabelled MIBG, administered i.v., is used in several clinical studies. These include palliation of the car...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kuin, A, Rutgers, M, Valk, M A van der, Beijnen, J H, Smets, L A
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 1999
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2362668/
https://ncbi.nlm.nih.gov/pubmed/10070872
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6690128
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!